Search Results - "Zorzetto, Marina Moreira Costa"

PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study by Pegram, Mark D., Bondarenko, Igor, Zorzetto, Marina Moreira Costa, Hingmire, Sachin, Iwase, Hirotaka, Krivorotko, Petr V., Lee, Keun Seok, Li, Rubi K., Pikiel, Joanna, Aggarwal, Rajesh, Ewesuedo, Reginald, Freyman, Amy, Li, Ray, Vana, Alicia, Yin, Donghua, Zacharchuk, Charles, Tan-Chiu, Elizabeth

“…Background This randomised, double-blind study compared PF-05280014 (a trastuzumab biosimilar) with reference trastuzumab (Herceptin®) sourced from the…”
Get full text

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial by de Pádua Souza, Cristiano, Carneiro, Ana Suellen Barroso, de Oliveira Lessa, Ana Cecília, Lacerda, Domício Carvalho, Paiva, Carlos Eduardo, Zorzetto, Marina Moreira Costa, de Freitas, Ana Julia Aguiar, Santana, Iara Viana Vidigal, de Oliveira, Marco Antonio, Palmero, Edenir Inêz, Marques, Márcia Maria Chiquitelli, Reinert, Tomás

“…Background Neoadjuvant chemotherapy (NACT) is the mainstay of treatment of stages II and III triple-negative breast cancer (TNBC). This study aims to evaluate…”
Get full text

Sequence of anthracyclines and taxanes in the neoadjuvant chemotherapy of HER2-negative breast cancer: Experience of a Brazilian oncological center by Preto, Daniel D’Almeida, Sanches, André Octavio Nicolau, Barroso, Alison Wagner Azevedo, Carbinatto, Alessandra Caroline Moretto, Veneziani, Ana Lima, Kons, Georgia, BUDIB, MARIA, Safro, Maria Augusta Zaffari, Pinto, Gustavo Sanches Faria, Bello Secco, Alan Felipe, Zorzetto, Marina Moreira Costa, Lacerda, Domicio, Paiva, Carlos Eduardo, Souza, Cristiano de Pádua

“…Abstract only e12105 Background: The best sequence of anthracyclines and taxanes in the neoadjuvant chemotherapy of HER2-negative breast cancer is still…”
Get full text